Neuromuscular Electrostimulation in Radiocephalic Fistula

NCT ID: NCT02925845

Last Updated: 2016-10-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2017-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* Objective: To analyze the effect of neuromuscular electrostimulation in the maturation of radiocephalic arteriovenous fistula (RC-AVF) patients with chronic kidney disease (CKD) stage 5-5D
* Design: Clinical Trial with medical devices, 18-month, single-center, within the hospital setting.
* Disease or disorder study: vascular Access maturation.
* Population: Patients with CKD stage 5-5D at the research center.
* Project duration: 78 weeks
* Methodology:
* Patients with CKD stages 5-5D that has undergone a native AV in service stations to give their informed consent and meeting the inclusion criteria will be included.
* At baseline two study groups were established:

* Group 1: neuromuscular electrostimulation
* Group 2: isometric exercises

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Objective: To analyze the effect of neuromuscular electrostimulation in the maturation of radiocephalic arteriovenous fistula (RC-AVF) patients with chronic kidney disease (CKD) stage 5-5D
* Design: Clinical Trial with medical devices, 18-month, single-center, within the hospital setting.
* Disease or disorder study: vascular Access maturation.
* Population: Patients with CKD stage 5-5D at the research center.
* Project duration: 78 weeks
* Methodology:
* Patients with CKD stages 5-5D that has undergone a native AV in service stations to give their informed consent and meeting the inclusion criteria will be included.
* At baseline two study groups were established:

* Group 1: neuromuscular electrostimulation
* Group 2: isometric exercises
* At baseline, patients included in the study the main demographic variables were collected, anthropometric, biochemical parameters, hemodynamic data, Eco Doppler of AV (ECO mapping) and prescribed medical treatment.
* Likewise, they will be made an assessment of their muscle strength by skinfold and upper limb static dynamometry in which was made the native AV.
* During the study period the following phases were established:

• Phase 1 (4 weeks):
* The control group will receive the usual care on an outpatient AV.
* Patients assigned to group, will perform a program of AV electrostimulation in the affected upper extremity (according to program) after 7 days of completion of native AV.
* At the end of this phase both groups were conducted an ECO doppler (ECO4s) AV regulated by Vascular Surgery.

• Phase 2 (8 weeks):
* The control group will receive the usual care on an outpatient AV.
* Patients assigned to group, will perform a program of AV electrostimulation in the affected upper extremity (according to program)
* At the end of this phase, both groups were conducted an ECO doppler (ECO8s) is regulated by the AV Vascular Surgery
* During all phases of the study, patients on hemodialysis follow their analytical controls programmed by Nephrology and receive medical treatment according to standard clinical practice.
* At the end of each phase of the study, all patients were performed an assessment of their muscle strength by centimetría, skinfold thickness and static dynamometry member in which AV has been made.
* Calendar: A provisional timetable is presented

* Presentation of the CEIC study: September 2014
* inclusion Period: 78 weeks
* Follow-up period: 2 months
* Close database: 1 month
* Statistical analysis: 1 month
* Source of funding: Not available

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arteriovenous Fistula

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Neuromuscular electrostimulation

Patients assigned to the group NMS, following the visit Day Hospital, in the first two hours of each HD session will perform a program of neuromuscular electrostimulation of the limb with the RC-AVF performed in the reference position of the flexors and extensors forearm at the tip intervened in each HD session on the stage previously established in the protocol (duration according to established program).

Group Type EXPERIMENTAL

Neuromuscular electrostimulation

Intervention Type DEVICE

The device CompexTheta 400i provided with various developmental programs rehabilitation exercise with different phases, types and current is used. an adaptive program (heating, toning, muscular atrophy, strength-endurance) will be established for each patient during the study period. It shall apply at the level of the muscle bellies of the flexor and extensor muscles of the forearm dela upper extremity AV created. Electrodes are positioned at the anatomical reference positions. The intensity of the current will increase until a tolerable muscle contraction and painless by the patient.

Isometric exercises

They will perform isometric exercises operated limb on an outpatient basis (repeated pressure rubber balls, heavy lifting 1-2 kg).

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neuromuscular electrostimulation

The device CompexTheta 400i provided with various developmental programs rehabilitation exercise with different phases, types and current is used. an adaptive program (heating, toning, muscular atrophy, strength-endurance) will be established for each patient during the study period. It shall apply at the level of the muscle bellies of the flexor and extensor muscles of the forearm dela upper extremity AV created. Electrodes are positioned at the anatomical reference positions. The intensity of the current will increase until a tolerable muscle contraction and painless by the patient.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged less than 18 years old
* Patients with tracking CCEE Nephrology than 3 months
* Patients with AV native AV upper limb without prior
* Patients give their written informed consent

Exclusion Criteria

* prior cardiovascular event (acute myocardial infarction, unstable angina, stroke ....) in the last 3 months.
* AV prior to HD in same upper extremity
* Not have given informed written consent
* Carrier cardiac pacemaker
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital de Terrassa

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lucia Martínez Carnovale

Medical Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lucía Inés Martínez Carnovale, MD

Role: PRINCIPAL_INVESTIGATOR

Hospital de Terrassa CST

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lucía Inés Martínez Carnovale

Terrassa, Barcelona, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lucía Inés Martínez Carnovale, MD

Role: CONTACT

+340615950992

Lucía Inés Martínez Carnovale, MD

Role: CONTACT

+34 615950992

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lucía Inés Martinez Carnovale, MD

Role: primary

+34 615950992

References

Explore related publications, articles, or registry entries linked to this study.

Brescia MJ, Cimino JE, Appell K, Hurwich BJ, Scribner BH. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. 1966. J Am Soc Nephrol. 1999 Jan;10(1):193-9. No abstract available.

Reference Type BACKGROUND
PMID: 9890327 (View on PubMed)

Leaf DA, MacRae HS, Grant E, Kraut J. Isometric exercise increases the size of forearm veins in patients with chronic renal failure. Am J Med Sci. 2003 Mar;325(3):115-9. doi: 10.1097/00000441-200303000-00003.

Reference Type BACKGROUND
PMID: 12640286 (View on PubMed)

Fontsere N, Mestres G, Yugueros X, Lopez T, Yuguero A, Bermudez P, Gomez F, Riambau V, Maduell F, Campistol JM. Effect of a postoperative exercise program on arteriovenous fistula maturation: A randomized controlled trial. Hemodial Int. 2016 Apr;20(2):306-14. doi: 10.1111/hdi.12376. Epub 2015 Oct 20.

Reference Type BACKGROUND
PMID: 26486682 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VES-COMPAVI-2014-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.